Can vibration therapy prevent bone loss?

July 6, 2026
Illustration of a bone on a UVA orange background surrounded by cracked, jagged UVA blue lines

The FDA-cleared Osteoboost belt sends vibrations through the skeleton and aims to slow bone loss in people with osteopenia. (Illustration by Johnny Utterback, University Communications)

A new vibrating belt designed to reduce bone loss in women is attracting attention after the U.S. Food and Drug Administration cleared it.

That is, instead of approving it. The distinction is important, says Dr. Suzanne Jan de Beur of the University of Virginia.

“FDA approval is usually for drugs and biologics. You have to show safety and efficacy. For FDA clearance ... manufacturers do not usually need to conduct new clinical trials,” she said. FDA approval requires evidence of both safety and efficacy.

Portrait of Dr. Suzanne Jan de Beur

UVA Health endocrinologist Dr. Suzanne Jan de Beur cares for patients with osteoporosis, metabolic bone disease and rare bone disorders. (Contributed photo)

The belt, called Osteoboost, is marketed for people with osteopenia, a condition marked by lower-than-normal bone density that has not progressed to osteoporosis. Worn around the hips and lower back, the device sends vibrations through the skeleton, mimicking the small stresses muscles and bones experience during walking or exercise. The goal is not to build new bone, but to help slow bone loss.

Osteoboost, which costs about $1,000, is currently on back order. It is the latest in a string of vibration-based devices that researchers and companies have explored as bone-health interventions for more than two decades.

Osteoboost points to a randomized, sham-controlled trial of 126 postmenopausal women with osteopenia. Researchers found no statistically significant benefit in the overall study population, though a subgroup of women who used the device regularly showed significantly less loss of vertebral bone strength as measured by biomechanical computed tomography over 12 months.

“It’s a small trial of postmenopausal women with close to normal bone density at baseline that demonstrated no difference in the treatment versus a placebo group in DXA-scanning after 12 months, which is our gold standard for measuring bone density and assessing fracture risk,” Jan de Beur said.

“I don’t recommend it because it’s expensive and the data supporting its effectiveness are limited,” she said.

Celebrating Our Shared History - VA250
Celebrating Our Shared History - VA250

An endocrinologist for 25 years, Jan de Beur tells her patients if they see a vibratory platform at the gym and stand on it for 10 minutes, “it is not going to harm you, I promise you that. I see women with osteoporosis in my practice, and this will not help them. I also don’t want them to forego other effective treatments, thinking that this is a substitute.”

Good general measures for bone health include a healthy diet, weight-bearing exercise and resistance training.

“Because we build our peak bone mass before age 30, I think it’s really important to pay attention to protein, calcium, vitamin D and weight-bearing exercise,” she said. “Getting 1,000 milligrams of calcium a day in your diet is important.”

While weighted vests can be a useful way to increase skeletal loading during weight-bearing activities such as walking, Jan de Beur cautioned they are not appropriate for everyone.

“If you have very low bone mass in your spine, you don’t want to put more weight on your spine,” she said. She generally advises people with balance problems or a high risk of falls to avoid weighted vests, since the added weight can increase the likelihood or severity of an injury.

Media Contacts

Jane Kelly

University News Senior Associate Office of University Communications

The Latest From Discovery & Innovation